Gilead says remdesivir helped moderate coronavirus patients improve
June 01, 2020 at 09:08 AM EDT
Gilead Sciences Inc said on Monday results from a study showed its antiviral drug remdesivir demonstrated significantly greater clinical improvement in patients with moderate COVID-19.
